Barclays »

Phathom Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $454k 50k 9.14
2023-09-30 $137k 13k 10.35
2023-06-30 $155k 11k 14.33
2023-03-31 $89k 13k 7.11
2022-12-31 $100k 8.9k 11.26
2022-09-30 $11k 976 11.27
2022-06-30 $40k 4.8k 8.39
2022-03-31 $94k 7.0k 13.49